![AG Mednet and Median Technologies Partnership Supports Global Clinical Trials Portfolio, Including Extensive Programs in China - G-MedTech News Center AG Mednet and Median Technologies Partnership Supports Global Clinical Trials Portfolio, Including Extensive Programs in China - G-MedTech News Center](https://www.g-medtech.com/news/wp-content/uploads/2019/07/20190709a-800x445.png)
AG Mednet and Median Technologies Partnership Supports Global Clinical Trials Portfolio, Including Extensive Programs in China - G-MedTech News Center
![Median Technologies Announces Performance for Its iBiopsy Lung Cancer Screening CADx With a Focus on Stage 1 Lung Cancer Characterization | Imaging Technology News Median Technologies Announces Performance for Its iBiopsy Lung Cancer Screening CADx With a Focus on Stage 1 Lung Cancer Characterization | Imaging Technology News](https://www.itnonline.com/sites/default/files/styles/content_large/public/Lung-CT.png?itok=YvJ0jsP-)
Median Technologies Announces Performance for Its iBiopsy Lung Cancer Screening CADx With a Focus on Stage 1 Lung Cancer Characterization | Imaging Technology News
![Validation clinique des technologies en intelligence artificielle : l'AP-HP et Median Technologies collaboreront sur iBiopsy® Validation clinique des technologies en intelligence artificielle : l'AP-HP et Median Technologies collaboreront sur iBiopsy®](https://www.actuia.com/wp-content/uploads/2020/03/Median-AP-HP-sant%C3%A9-iBiopsy.png)
Validation clinique des technologies en intelligence artificielle : l'AP-HP et Median Technologies collaboreront sur iBiopsy®
![Median Technologies Completes FDA Q-Submission Phase for Lung Cancer Screening Software | Clinical Lab Products Median Technologies Completes FDA Q-Submission Phase for Lung Cancer Screening Software | Clinical Lab Products](https://clpmag.com/wp-content/uploads/2023/01/Lung-Cancer-800x640.jpg)